GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NEOFECT Co Ltd (XKRX:290660) » Definitions » Research & Development

NEOFECT Co (XKRX:290660) Research & Development : ₩1,770 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is NEOFECT Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. NEOFECT Co's Research & Development for the three months ended in Sep. 2024 was ₩407 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was ₩1,770 Mil.


NEOFECT Co Research & Development Historical Data

The historical data trend for NEOFECT Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NEOFECT Co Research & Development Chart

NEOFECT Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 1,240.12 1,653.97 1,499.60 1,944.64 1,545.55

NEOFECT Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 257.54 509.21 456.88 397.20 406.77

NEOFECT Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,770 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NEOFECT Co  (XKRX:290660) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


NEOFECT Co Research & Development Related Terms

Thank you for viewing the detailed overview of NEOFECT Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


NEOFECT Co Business Description

Traded in Other Exchanges
N/A
Address
152, Jukjeon-ro, 401 West Hall, Dankook, University, 152, Suji-gu, Gyeonggi-do, Yongin-si, KOR
NEOFECT Co Ltd is a Korea based company engaged in developing rehab training products and services. The company has developed innovative smart rehabilitation solutions to help patients with neurological and musculoskeletal injuries. Products offered by the company include RAPAEL Smart Glove, RAPAEL Smart Kids, RAPAEL Smart Board, RAPAEL SMART PEGBOARD, RAPAEL Cognition, NeoMano, and RAPAEL Suite.

NEOFECT Co Headlines

No Headlines